Reviewing 2014 on Oncology Central – our top content of the year

We’ve been having a look back at what a great year 2014 was for Oncology Central this week and reviewing which of the year’s content you found most engaging.

Below you can find a full round up of the 10 top read articles and news stories of the year – a diverse list covering many areas of the broad field of oncology. Have you read them yet? Catch up on 2014 on the OC now and feel free to leave us your comments.

Top read articles of 2014:
Engulfing losers by winners in cancer: do cancer stem cells catch eat-me signals from noncancer stem cells?
Grading neuroendocrine tumors: are we there?
How can we manage resistance to antiangiogenic drugs?
Considerations on the prognostic and predictive significance of HLA-G in breast cancer
Positive sentinel lymph node: the evolution of axillary surgery and intraoperative assessment of sentinel lymph nodes
γδ T cells as a potential tool in colon cancer immunotherapy
Current management of colorectal liver metastases
Tamoxifen as the first successful targeted therapy in cancer: the gift that kept on giving
Clinical significance of FGFR1 gene amplification in lung cancer patients
Waldenström macroglobulinemia at 70

Top read headlines of 2014:
Glioblastoma animal studies result in trial of potential new combination therapy
Ultraviolet light-induced mutation drives many skin cancers, researchers find
Study shows screening for prostate cancer could reduce prostate cancer deaths by one fifth
Breast cancer recurrence rate may be reduced in obese women who take NSAIDs
Phase III rolapitant trial demonstrates significant reductions in nausea and vomiting
Cirmtuzumab enters Phase I trial for the treatment of chronic lymphocytic leukemia
Novel breast cancer biomarker crosses subtype boundaries
Novel gene could predict metastatic potential of breast tumors
Osteoporosis treatment reduces risk of breast cancer bone metastases in first study of its kind
‘Breakthrough Therapy’ shows promise in acute lymphoblastic leukemia